Clinical Trial Update: A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain [Phase 4]

View source ↗

Summary

A Phase 4 multicenter open-label trial evaluating parecoxib followed by valdecoxib for postoperative pain after laparoscopic surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Parecoxib (parecoxib)
• Valdecoxib (valdecoxib)

Snippet

Sponsor: Pfizer | Conditions: Pain, Post Surgical | Phase 4 | Status: TERMINATED